Chennai NewsNews

Biotech Firm Stops Animal Experiments, Adopts Virtual Learning

A biotechnology company in Trichy, Tamil Nadu, called Evolute Bioscience, has made a groundbreaking decision to stop all experiments on animals. Instead, the firm will use virtual simulation software for its pharmacology education and research programs. This move was inspired by discussions with PETA India, which highlighted the benefits of non-animal methods. PETA partnered with Simcology India, a company based in Himachal Pradesh, to provide the free software. The agreement between Evolute Bioscience and PETA means that no living or dead animals will be used in undergraduate or postgraduate pharmacology education, training, or research. This decision will save the lives of many animals, including mice and zebra fish, which were previously used for experiments. Evolute Bioscience had planned to use at least 50 mice annually for disease model testing and 60 zebra fish for other experiments, but these plans have been canceled. The firm will transition fully to virtual simulations as soon as the non-animal software is finalized with Simcology’s help. The new simulation tools allow pharmacology students to perform experiments using computer-assisted learning methods instead of harming animals. This approach eliminates the need for animals to be exposed to chemicals, diseases, or painful procedures before being euthanized. PETA India scientist Anjana Aggarwal emphasized that modern technology provides better and more ethical ways to train pharmacology students. She noted that animals like mice are not always relevant to human pharmacology education and encouraged other institutions to follow Evolute Bioscience’s lead. Evolute Bioscience’s managing director, Preyenga Saravanan, expressed gratitude to PETA for the software donation and highlighted how it improves both animal welfare and the quality of education for students. In 2022, India’s National Medical Commission updated its guidelines for pharmacology education, recommending non-animal methods and making some animal experiments optional. Many students are uncomfortable with animal dissection and experimentation, and virtual simulations offer a cruelty-free alternative that is also cost-effective and sustainable. This shift to virtual learning not only spares animal lives but also prepares students with modern tools for their future careers in medicine and science. Evolute Bioscience’s decision sets an important example for other institutions to follow, promoting compassion and innovation in education.